Thryve Peptides
AOD 9604 (5mg)
AOD 9604 (5mg)
Couldn't load pickup availability
AOD-9604 5MG
Fragment peptide analog — designed for controlled metabolic and lipolytic research studies.
- AOD-9604 is a synthetic peptide fragment (176–191) of the human growth hormone sequence.
- Studied in pre-clinical and in vitro models for its potential activity on lipid metabolism and fatty acid oxidation pathways.
- Every batch tested by Vanguard Laboratory for peptide identity, purity, and sequence accuracy.
For laboratory research use only. Not for human or veterinary consumption.
Scientific Evidence
AOD-9604 is a 15-amino-acid peptide fragment derived from the C-terminal region of growth hormone. It has been shown in experimental settings to regulate lipolysis and inhibit lipogenesis through specific receptor-mediated pathways (PubMed 17302380).
Research indicates potential effects on beta-oxidation and energy metabolism without influencing insulin sensitivity or blood glucose levels in animal studies (PubMed 15040866).
Laboratory trials have also explored AOD-9604 as a non-lipogenic analog for evaluating growth hormone–related metabolic pathways (PubMed 22666507).
Regulatory Status: AOD-9604 is not FDA-approved for human or veterinary use. This product is supplied strictly for laboratory research applications.
